Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop
Primary membranous nephropathy is a common cause of adult-onset nephrotic syndrome, with an overall incidence of 12 cases per million per year. Primary membranous nephropathy is an autoimmune kidney disease; however, primary membranous nephropathy autoantigens remained elusive until 2009,...
Saved in:
| Main Authors: | Marco Prunotto, Patrick H. Nachman, Barbara S. Gillespie, Laurence H. Beck, Aliza M. Thompson, Austin H. Hu, Elizabeth A. Stafford, Josh M. Tarnoff, Brad H. Rovin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-03-01
|
| Series: | Glomerular Diseases |
| Online Access: | https://karger.com/article/doi/10.1159/000544808 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypercoagulability and dyslipidemia in membranous nephropathy with anti-phospholipase A2 receptor antibodies
by: Michael Kitlinski, et al.
Published: (2025-12-01) -
Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
by: Keying Fu, et al.
Published: (2022-01-01) -
Recurrence of Phospholipase A2 Receptor–Associated Membranous Nephropathy in the Absence of Serum Anti-Phospholipase A2 Receptor Antibodies Reappearance
by: Ilias Bensouna, et al.
Published: (2025-03-01) -
The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy
by: Yunyun Liu, et al.
Published: (2024-12-01) -
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation
by: Marion Cremoni, et al.
Published: (2024-12-01)